Adagene (ADAG) Common Equity (2019 - 2026)
Adagene (ADAG) posted Common Equity of $89.45 million for the quarter ended Jun 30, 2026, up 136.0% from $37.91 million a year earlier.
Powered by 
Analysis
Adagene (ADAG) Common Equity (2019 - 2026) Analysis & Trends
As of Dec 31, 2025, Adagene's Common Equity came in at $35.35 million, down 30.0% from the prior year.
- Annual Common Equity has declined for four consecutive years.
- In prior years, Adagene's Common Equity was $50.52 million in the year ended Dec 31, 2024 (-28.4%), $70.56 million in the year ended Dec 31, 2023 (-15.1%), $83.09 million in the year ended Dec 31, 2022 (-46.9%) and $156.56 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Common Equity since the quarter ended Jun 30, 2022.
- On a year-over-year basis, Common Equity increased in 1 of the last four quarters, with growth averaging 11.1%.
- The strongest year-over-year quarter for Common Equity in the past five years was the quarter ended Jun 30, 2026, with growth of 136.0%; the weakest was the quarter ended Dec 31, 2022, with a decline of 46.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Adagene | 189.54 Mn | 189.54 Mn | - | 89.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 89.45 Mn |
| Dec 31, 2025 | 35.35 Mn |
| Jun 30, 2025 | 37.91 Mn |
| Dec 31, 2024 | 50.52 Mn |
| Jun 30, 2024 | 56.59 Mn |
| Dec 31, 2023 | 70.56 Mn |
| Jun 30, 2023 | 82.79 Mn |
| Dec 31, 2022 | 83.09 Mn |
| Jun 30, 2022 | 112.68 Mn |
| Dec 31, 2021 | 156.56 Mn |
| Jun 30, 2021 | 186.22 Mn |
| Dec 31, 2020 | -89.39 Mn |
| Dec 31, 2019 | -57.01 Mn |
API Access
Adagene Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ADAG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ADAG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ADAG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();